Latest Breaking News On - Aused inva us45781m1018 - Page 1 : comparemela.com

Sulbactam-durlobactam is the first pathogen-targeted therapy under investigation for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by. | May 11, 2023

United statesKeith kayeCenters for diseaseDrug administrationExchange commissionInnoviva incDivision of allergyEntasis therapeutics incSecurities exchangeGlaxo group limitedAntimicrobial drugs advisory committeeJolla pharmaceutical companyWorld health organizationInnoviva specialty therapeuticsLancet infectious diseasesSerious infections